Speaker illustration

Doctor Lieke Feijen

Princess Maxima Center, Utrecht (Netherlands (The))

Lieke Feijen is senior scientist with the DCCSS LATER group Kremer, since 2015. She finished her PhD in 2015, the topic of her thesis was cardiotoxicity after childhood cancer treatment. She is a co-PI at a large Dutch Heart Association grant (2016), a co-PI at a Pilot study funded by KiKa (2020) and was the work package coordinator in a large pan-European project about late effects, specifically cardiotoxicity.

Cardiac care 10 years after childhood cancer.

Event: ESC Congress 2022

Topic: Cardiovascular Disease in Special Populations

Session: Long-term cardiac care in cancer patients: how to do it right


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb